Section 1. Section 49-20-423 is enacted to read:49-20-423. Payment for transgender treatment or procedure using public employee insurance prohibited -- Exception -- Coverage for detransitioning.(1)As used in this section:(a)"Hormonal transgender treatment" means the same as that term is defined in Section 58-1-603.(b)"Public employee insurance" means the Public Employees' Benefit Insurance Program created in Section 49-20-103.(2)Public employee insurance may not, either directly or indirectly, offer coverage, or be used to pay or otherwise reimburse, for the performance of:(a)except as provided in Subsection (3), hormonal transgender treatment;(b)a primary sex characteristic surgical procedure as defined in Section 58-67-102; or(c)a secondary sex change characteristic surgical procedure as defined in Section 58-67-102.(3)If, on May 5, 2026, an individual was undergoing hormonal transgender treatment that was, as of that date, payable or reimbursable under public employee insurance, the individual may complete that course of treatment on the same terms of payment or reimbursement that were available for that course of treatment on May 5, 2026, until that course of treatment ends, if the physician overseeing that course of treatment determines that it is medically necessary to continue the course of treatment.(4)If, before May 6, 2026, public employee insurance paid or otherwise reimbursed a person, either directly or indirectly, for the treatment or a surgical procedure described in Subsection (2) that was performed before May 6, 2026, to transition an individual from the individual's biological sex, public employee insurance shall offer the same type and amount of coverage for treatment or a surgical procedure to restore that individual, to the extent possible, to that individual's biological sex.